These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6140010)

  • 41. Norepinephrine release and the activation of tyrosine hydroxylase during nerve stimulation.
    Lee FL; Weiner N
    Proc West Pharmacol Soc; 1976; 19():91-6. PubMed ID: 11507
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of calcium on dopamine synthesis and tyrosine hydroxylase activity in rat striatum.
    Kapatos G; Zigmond MJ
    J Neurochem; 1982 Aug; 39(2):327-35. PubMed ID: 6123555
    [No Abstract]   [Full Text] [Related]  

  • 43. Activation by cyclic AMP of soluble tyrosine hydroxylase in bovine adrenal medulla.
    Morita K; Oka M
    FEBS Lett; 1977 Apr; 76(2):148-50. PubMed ID: 16777
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro phosphorylation of a purified preparation of bovine corpus striatal tyrosine hydroxylase.
    Edelman AM; Raese JD; Lazar MA; Barchas JD
    Commun Psychopharmacol; 1978; 2(6):461-5. PubMed ID: 34498
    [No Abstract]   [Full Text] [Related]  

  • 45. Regulation of tyrosine hydroxylase activity in retinal cell suspensions: effects of potassium and 8-bromo cyclic AMP.
    Iuvone PM; Marshburn PB
    Life Sci; 1982 Jan; 30(1):85-91. PubMed ID: 6119599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosine hydroxylase:--examination of conditions influencing activity in pheochromocytoma, adrenal medulla and striatum.
    Hegstrand LR; Simon JR; Roth RH
    Biochem Pharmacol; 1979; 28(4):519-23. PubMed ID: 34406
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term haloperidol treatment and factors affecting the activity of striatal tyrosine hydroxylase.
    Lovenberg W; Alphs L; Pradhan S; Bruckwick E; Levine R
    Adv Biochem Psychopharmacol; 1980; 24():9-15. PubMed ID: 6105810
    [No Abstract]   [Full Text] [Related]  

  • 48. Tyrosine hydroxylase activation in depolarized dopaminergic terminals--involvement of Ca2+-dependent phosphorylation.
    El Mestikawy S; Glowinski J; Hamon M
    Nature; 1983 Apr; 302(5911):830-2. PubMed ID: 6133218
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of S-adenosylhomocysteine on sulfhydryl xenobiotic transmethylases in rat liver.
    Loo G; Smith JT
    Biochem Biophys Res Commun; 1985 Apr; 128(2):965-71. PubMed ID: 3994729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new mechanism for regulation of tyrosine 3-monooxygenase by end product and cyclic AMP-dependent protein kinase.
    Okuno S; Fujisawa H
    J Biol Chem; 1985 Mar; 260(5):2633-5. PubMed ID: 2857715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes.
    Kapatos G; Zigmond MJ
    J Pharmacol Exp Ther; 1979 Mar; 208(3):468-75. PubMed ID: 34711
    [No Abstract]   [Full Text] [Related]  

  • 52. Striatal tyrosine hydroxylase: comparison of the activation produced by depolarization and dibutyryl-cAMP.
    Simon JR; Roth RH
    Mol Pharmacol; 1979 Jul; 16(1):224-33. PubMed ID: 39245
    [No Abstract]   [Full Text] [Related]  

  • 53. Analytical characterization of a sensitive radioassay for tyrosine hydroxylase activity in rodent striatum.
    Khan HA
    Neurochem Res; 2004 Aug; 29(8):1467-72. PubMed ID: 15260122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine hydroxylase activation in mesocortical 3,4-dihydroxyphenylethylamine neurons following footshock.
    Iuvone PM; Dunn AJ
    J Neurochem; 1986 Sep; 47(3):837-44. PubMed ID: 2874194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for involvement of protein kinase in the activation by adenosine 3':5'-monophosphate of brain tyrosine 3-monooxygenase.
    Morgenroth VH; Hegstrand LR; Roth RH; Greengard P
    J Biol Chem; 1975 Mar; 250(5):1946-8. PubMed ID: 234470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The regulation of the kinetic state of striatal tyrosine hydroxylase and the role of postsynaptic dopamine receptors.
    Zivkovic B; Guidotti A; Costa E
    Brain Res; 1975 Jul; 92(3):516-21. PubMed ID: 240486
    [No Abstract]   [Full Text] [Related]  

  • 57. Does cyclic AMP-dependent phosphorylation account for the activation of tyrosine hydroxylase produced by depolarization of central dopaminergic neurons?
    Bustos G; Roth RH
    Biochem Pharmacol; 1979 Oct; 28(19):3026-8. PubMed ID: 42409
    [No Abstract]   [Full Text] [Related]  

  • 58. Differential inhibition of activated tyrosine hydroxylase.
    Bennett DB; Coscia CJ
    Arch Biochem Biophys; 1983 Dec; 227(2):562-9. PubMed ID: 6141765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
    Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opiate-receptors in substantia nigra: role in the regulation of striatal tyrosine hydroxylase activity.
    Gale K; Moroni F; Kumakura K; Guidotti A
    Neuropharmacology; 1979 Apr; 18(4):427-30. PubMed ID: 36574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.